Here are the 424B prospectus supplements from ArrowMark Financial Corp. (BANX) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow BANX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BANX filings page.
ArrowMark Financial Corp. is conducting a transferable rights offering for up to 2,604,156 new common shares of BANX. Shareholders of record at 5:00 p.m. Eastern on January 22, 2026 receive one Right for each existing share and can buy one new share for every three Rights (a 1‑for‑3 offer), with an over‑subscription privilege for those who fully exercise.
The Subscription Price will be set at 92.5% of the average market price over the Expiration Date plus the prior four trading days, but not below 90% of NAV. Based on an estimated price of $19.93, the Fund projects gross proceeds of about $51.9 million and net proceeds of roughly $49.3 million after a $0.75 per‑share (3.75%) sales load and other offering costs.
The Fund plans to invest proceeds in its banking‑related strategy, including regulatory capital relief securities, and may temporarily pay down its credit facility. If fully subscribed at the estimated price, management estimates NAV per share would decline by about $0.76, or 3.5%, and non‑participating holders would experience ownership dilution, though Rights will trade on NASDAQ under “BANXR”, allowing holders to sell them.
ArrowMark Financial Corp. plans an at-the-market offering of up to $25,000,000 of common stock, sold from time to time through ALPS Distributors under a distribution agreement. Shares will only be issued at or above the then-current net asset value per share plus the selling commission, so the company cannot sell new stock below NAV.
ArrowMark is a non-diversified, closed-end fund focused on current income from banking-related securities, especially regulatory capital relief instruments, preferred and subordinated debt, and CLO interests tied to banks and other financial institutions. It uses leverage via a credit facility and generally targets borrowings of about 30% of Managed Assets, with a management fee of 1.75% of Managed Assets paid to its adviser.
For the current fiscal year, total annual expenses are estimated at 7.40% of net assets, reflecting management fees, interest on borrowings and other operating costs. The distributor will receive a 1.00% commission on gross proceeds from ATM sales, with a portion payable to UBS Securities as sub-placement agent. Net proceeds are expected to be invested in line with the fund’s income-focused banking strategy within roughly three months after completion of the offering.